Johnson, Teresa R <br/><br/>
IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Feb 2003 
 - 2037-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.170.4.2037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Viral--metabolism<br/>Antibody Specificity<br/>Cell Line<br/>Cytokines--biosynthesis<br/>Formaldehyde--pharmacology<br/>HN Protein--immunology<br/>Humans<br/>Immunization<br/>Inflammation--immunology<br/>Interleukin-13--antagonists & inhibitors<br/>Interleukin-4--antagonists & inhibitors<br/>Lung--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Knockout<br/>Neutralization Tests<br/>Pulmonary Eosinophilia--immunology<br/>Receptors, Interleukin-4--deficiency<br/>Respiratory Syncytial Virus Infections--immunology<br/>Respiratory Syncytial Virus Vaccines--administration & dosage<br/>Respiratory Syncytial Viruses--immunology<br/>Th2 Cells--immunology<br/>Vaccines, Inactivated--administration & dosage<br/>Vaccinia virus--immunology<br/>Viral Envelope Proteins<br/>Viral Load